CERS Q3 2025 Earnings — Cerus Corporation Revenue & Financial Results | Market Cap Arena

CERSCerus Corporation

$358M

Q3 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$53M+14.5% YoY

Gross Profit

$28M53.4% margin

Operating Income

$1M2.3% margin

Net Income

-$19,000-0.0% margin

EPS (Diluted)

$-0.00

QoQ Revenue Growth

+0.5%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

$94,000

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$215M

Total Liabilities

$153M

Stockholders' Equity

$61M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$53M	$46M	+14.5%
Gross Profit	$28M	$26M	+7.4%
Operating Income	$1M	-$961,000	+228.6%
Net Income	-$19,000	-$3M	+99.4%

Revenue Segments

Product

$53M87%

Government Contract

$8M13%

Geographic Segments

North America

$35M66%

Europe Middle East And Africa

$17M32%

Other

$923,0002%